Steve Weldon Letter of Resignation, dated November 11, 2020

EX-10.21 4 gtbp_ex1021.htm STEVE WELDON LETTER OF RESIGNATION gtbp_ex1021
Exhibit 10.21
November 11, 2020
Anthony Cataldo
GT Biopharma Inc.
9350 Wilshire Blvd., Suite 203
Beverly Hills, CA 990212
Mr. Cataldo:
This letter is my notice of resignation as the Chief Financial Officer and Director of GT Biopharma, Inc. effective immediately.
/s/ Steven Weldon
Steven Weldon, MBA, CPA